Health
Existing drug reduces obesity and fatty liver in mice without changes in food intake or daily activity – News-Medical.Net
Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and…
Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity and fatty liver in mice and improves their heart function — without changes in food intake or…
Continue Reading
-
Noosa News22 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News23 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025
-
Noosa News22 hours agoFatal traffic crash, Noosa – Sunshine Coast
